These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7106061)
1. A follow-up study of plasma beta-N-acetylglucosaminidase activity and diabetic retinopathy--observed for 2 years. Lee Y; Akanuma Y; Kosaka K; Kuzuya N Endocrinol Jpn; 1982 Feb; 29(1):77-80. PubMed ID: 7106061 [TBL] [Abstract][Full Text] [Related]
2. Studies of plasma beta-N-acetylglucosaminidase activity in experimental and clinical diabetes mellitus. Lee YS; Akanuma Y; Iwamoto Y; Kosaka K; Kuzuya N Endocrinol Jpn; 1980 Aug; 27(4):463-9. PubMed ID: 6450678 [TBL] [Abstract][Full Text] [Related]
3. beta-N-acetylglucosaminidase and beta-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy. Pitkänen E; Kyllästinen M; Koivula T; Hormila P Diabetologia; 1980 Apr; 18(4):275-8. PubMed ID: 7418953 [TBL] [Abstract][Full Text] [Related]
4. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects]. Melosi A; Ricci F Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040 [TBL] [Abstract][Full Text] [Related]
5. A six-year follow-up of the relationship between N-acetyl-beta-glucosaminidase and albuminuria in relation to retinopathy. Skrha J; Haas T; Sperl M; Stibor V; Stolba P Diabet Med; 1991 Nov; 8(9):817-21. PubMed ID: 1837508 [TBL] [Abstract][Full Text] [Related]
7. N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes. Miralles JM; Corrales JJ; Garcia-Diez LC; Cabezas JA; Reglero A Clin Chim Acta; 1982 Jun; 121(3):373-8. PubMed ID: 7105401 [TBL] [Abstract][Full Text] [Related]
8. N-Acetyl-beta-D-glucosaminidase levels and the onset of diabetic microangiopathy. Whiting PH; Ross IS; Borthwick LJ Ann Clin Biochem; 1983 Jan; 20 Pt 1():15-9. PubMed ID: 6838142 [TBL] [Abstract][Full Text] [Related]
9. Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus. Skrha J; Hodinár A; Kvasnicka J; Stibor V; Sperl M; Stolba P; Hilgertová J Clin Chim Acta; 1994 Sep; 229(1-2):5-14. PubMed ID: 7988055 [TBL] [Abstract][Full Text] [Related]
10. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus]. Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872 [TBL] [Abstract][Full Text] [Related]
11. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy]. Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037 [TBL] [Abstract][Full Text] [Related]
12. Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination. Jovanović VB; Dimitrijević-Srecković VS; Mandić LM J Clin Lab Anal; 2008; 22(4):307-13. PubMed ID: 18623113 [TBL] [Abstract][Full Text] [Related]
13. Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics. Whiting PH; Ross IS; Borthwick L Clin Chim Acta; 1979 Mar; 92(3):459-63. PubMed ID: 436284 [TBL] [Abstract][Full Text] [Related]
14. Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Agardh CD; Agardh E; Isaksson A; Hultberg B Clin Chem; 1991 Oct; 37(10 Pt 1):1696-9. PubMed ID: 1914168 [TBL] [Abstract][Full Text] [Related]
15. Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Shimojo N; Kitahashi S; Naka K; Fujii A; Okuda K; Tanaka S; Fujii S Metabolism; 1987 Mar; 36(3):277-80. PubMed ID: 2881186 [TBL] [Abstract][Full Text] [Related]
16. [Activity of beta-N-acetylglucosaminidase in chronic alcoholic liver disease]. Pinto C; Galvão-Teles A; Monteiro E; Marques C; Azevedo M; Manso C Acta Med Port; 1990; 3(2):75-9. PubMed ID: 2349891 [TBL] [Abstract][Full Text] [Related]
17. N-acetyl-beta-glucosaminidase isoenzymes in serum and urine of patients with diabetes mellitus. Severini G; Aliberti LM; Di Girolamo M Clin Chem; 1988 Dec; 34(12):2430-2. PubMed ID: 3197280 [TBL] [Abstract][Full Text] [Related]
18. Serum beta-N-acetylglucosaminidase and beta-glucuronidase activities in silicosis patients and in workers exposed to silica dust. Koskinen H; Järvisalo J; Pitkänen E; Mutanen P; Zitting A Br J Dis Chest; 1984 Jul; 78(3):217-24. PubMed ID: 6331485 [TBL] [Abstract][Full Text] [Related]
19. [Isoenzymes of serum N-acetyl-beta-D-glucosaminidase in insulin-dependent diabetic subjects]. Clemenzia G; Persichetti S; Sagliaschi G; Gallo G; Re M; Ronchi F; Russo G; Zappi P; Scibinetti F; Amici A Minerva Med; 1988 Jul; 79(7):547-9. PubMed ID: 3405458 [TBL] [Abstract][Full Text] [Related]
20. The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Myśliwiec M; Zorena K; Balcerska A; Myśliwska J; Lipowski P; Raczyńska K Clin Biochem; 2006 Aug; 39(8):851-6. PubMed ID: 16696964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]